Definitive Contract 75F40121C00137

Award Date 9/8/21
Potential Completion Date 9/7/26
Potential Value $1M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Basic Research
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to The Children's Hospital of Philadelphia (CHOP) from the National Institute of Diabetes and Digestive and Kidney Diseases, a civilian agency within the Department of Health and Human Services. The $18,779,641.25 definitive contract is for research and development facilities, with a period of performance ending on March 31, 2010. The contract does not have a set-aside designation. CHOP, a leading pediatric hospital and research facility, is the prime...
This is a $276,916.98 federal contract awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services, to The Children's Hospital of Philadelphia (CHOP) Research Institute. The contract, which is a definitive contract with cost-no-fee pricing, is for the National Children's Study. The contract does not have a set-aside designation. As a leading pediatric hospital and research institution, CHOP leverages...
This is a definitive, firm fixed-price contract awarded by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to The Children's Hospital of Philadelphia (CHOP) Research Institute on September 30, 2017 for a value of $322,263.00. The contract does not have a set-aside designation and is for the performance of "OTHER FUNCTIONS" with a completion date of June 30, 2019. CHOP is a pediatric healthcare provider, research institution, and...
This is a cost-no-fee delivery order awarded by the National Heart Lung and Blood Institute, a civilian agency within the U.S. Department of Health and Human Services, to The Children's Hospital of Philadelphia (CHOP). The $859,605.14 contract is for GTRP AAV laboratory services for Dr. Radar 1267 during fiscal year 2015. No set-aside was used for this award. The contract has an ultimate completion date of June 14, 2017. CHOP, a leading pediatric hospital and research facility, has been...
This is a firm fixed price contract awarded by the Department of Health and Human Services Food and Drug Administration to The Children's Hospital of Philadelphia (CHOP) on September 29, 2020. The $347,335.00 contract is for research on the incidence and outcomes of human adenovirus infection and disease among a multicenter observational cohort of pediatric allogeneic hematopoietic cell transplant recipients. The contract has a completion date of September 29, 2023 and does not have a...
This is a firm fixed-price purchase order contract awarded by the U.S. Army Medical Command (MEDCOM) to The Children's Hospital of Philadelphia (CHOP) for data analysis and reporting services. The contract has a ceiling value of $149,998.95 and a period of performance through December 28, 2017. The contract does not have a set-aside designation. As a leading pediatric research institution, CHOP has been awarded numerous federal contracts and grants from agencies such as the Department of...
This is a $393,676.59 delivery order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to The Children's Hospital of Philadelphia (CHOP) Research Institute. The contract is for GTRP AAV lab services in support of the NEI (National Eye Institute) for fiscal year 2014, and has a period of performance through June 1, 2017. The contract is not a set-aside and is a Cost No Fee type arrangement. CHOP is a leading...
This is a firm fixed-price purchase order contract awarded by the U.S. Department of Health and Human Services, Office of the Assistant Secretary for Administration, to the Children's Hospital of Philadelphia (CHOP) on August 17, 2016. The contract, valued at $94,993.91, is for the provision of the Child Core Set of Measures used by Medicaid and the Children's Health Insurance Program (CHIP). The contract does not have a set-aside designation. CHOP, a leading pediatric hospital and research...
This is a definitive, firm-fixed price contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to The Children's Hospital of Philadelphia (CHOP) on July 1, 2020. The contract, valued at $449,879.00, is for a project titled "PERINATAL COVID-19 IN THE UNITED STATES: SURVEILLANCE AND EPIDEMIOLOGY" with a completion date of September 30, 2022. The contract does not have a set-aside designation. CHOP, a non-profit pediatric hospital and...
This is a $143,750.00 firm fixed price purchase order awarded by the Department of Transportation National Highway Traffic Safety Administration to The Children's Hospital of Philadelphia (CHOP) for CCHIPS - ANNUAL MEMBERSHIP DUES. The contract has a completion date of March 31, 2023 and was awarded on July 16, 2018. There is no set-aside designation indicated. CHOP is a non-profit pediatric hospital and research center that has received numerous federal contracts and grants from agencies like...

The Children's Hospital of Philadelphia (CHOP) has been awarded a Definitive Contract by the Food and Drug Administration (FDA) for $1,048,942.00 to conduct research and development on drug development for pediatric cancers. The contract is a renewal of the FDA's Broad Agency Announcement (BAA) for Advanced Regulatory Science, which seeks proposals across areas of regulatory science to modernize research and support the FDA's mission. The contract has no set-aside designation. As a leading pediatric hospital and research institution, CHOP has significant expertise in areas like pediatric cancers, rare diseases, and genetic disorders, and frequently collaborates with other organizations on federally funded research projects and clinical trials.

Generated 6/7/24, 11:18 AM